TSANZ home

Results for "events"

Home 5 Search query for: events
Results for "events"
VOLUME 7.06 – JULY 2022

VOLUME 7.06 – JULY 2022

Research Roundup:

July 2022

Welcome Message

Welcome to another issue of Research Roundup. Best of luck to everyone who applied for the recent Medical Research Future Fund grants. I hope you have all caught up on some sleep by now!

Speaking of grants there is a whole host of opportunities listed in this newsletter and quite a few are closing soon. TSANZ has two travel grants closing at the start of August, one for the inaugural TSANZSRS Education Hub, and one for the TSANZSRS NZ Branch ASM. Speaking of the NZ Branch ASM, their new investigator award closes on the 14th of August. Outside of TSANZ Cure4CF’s Holckner Family CF Impact Grant is offering up to $500,000 for Cystic Fibrosis research and this grant closes on the 5th of August. For those working outside of research ELF has grants of up to €1,000 for not-for-profit organisations, patient groups and healthcare professionals closing very soon, on the 31st of July.

In addition, the TSANZSRS ASM abstract linked awards have just opened! Details for these awards are outlined below. In related and exciting news, the value of both the Ann Woolcock New Investigator Award and Janet Elder International Travel Awards have increased to $5k each. A lot of the abstract linked awards are targeted to early-mid career researchers. If you fit into this category and have been thinking about submitting an abstract to TSANZ, you should absolutely consider extending your application to go for one, or even both of these awards at the same time. It may just be the steppingstone that takes you that little bit further along your career path.

The Limbic, Respirology and Respiratory Research Review have some excellent reads, and if you’re after further educational opportunities there are some interesting webinars across the next week. RACP are running a COVID webinar series in July, there’s one more session you can catch on the 28th; “COVID-19: Where to now?”. Next month on the 3rd of August ACTnet running a seminar on TB genomics.

Finally, if you ever find yourself feeling a little deprived of motivation, I strongly suggest a google search for Admiral McRaven’s 2014 commencement speech. He outlines 10 life lessons from his time as a navy seal…no wait, don’t stop reading yet. Seriously. I now have each of these printed on 10 A4 pieces of paper on the wall in my office. He has been and continues to be a source of inspiration for me, and for those of you who may be looking for that little push to open your next grant application template, this may be the productive procrastination activity for you.

As always, happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

TSANZSRS NZ Branch Meeting 2022 New Investigator Award – Abstract Submissions close 14th August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

TSANZSRS Annual Scientific Meeting 2023

Call for Abstracts

On behalf of the Organising Committees, we warmly invite you to attend the Annual Scientific Meeting of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand. The TSANZSRS 2023 meeting will be held at Te Pae Christchurch Convention Centre from 25th – 28th March 2023 with opportunities to attend pre-conference Postgraduate Courses on Friday 24th March.

TSANZ abstract awards are now open!

For more information regarding the TSANZSRS 2023 ASM and how to apply for the above awards visit https://www.tsanzsrsasm.com/

 

TSANZ Surveys

Help us improve our educational offerings to members and our skill base by completing the below surveys!

TSANZ Methodology Survey

Evidence-based practice skills among members of the TSANZ

The TSANZ is conducting this voluntary survey to identify members who have specific evidence-based practice (EBP) methodology skills to support the production of position statements and clinical practice guidelines by the Society.

We are asking you to fill out a questionnaire, which should take approximately 15 minutes to complete.

The study gives you an opportunity to tell us about:

  • The skills you have to perform specific elements of a systematic review for the development of Society documents
  • Your interest to learn/improve specific skills or share/teach specific skills

Survey link: https://forms.office.com/r/W6SUisW70g

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Education Hub Logo

Education Hub Travel Grants

The TSANZ and ANZSRS have established a scheme to assist early-career members to attend the TSANZSRS Education Hub. This is to encourage active participation in the Hub and will be awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields.

The travel grant for the 2022 TSANZSRS Education Hub will be to contribute to travel costs to maximum of AU$250*
* based on individual travel requirements with submitted evidence of costs.

Please click here for more information on the travel grant guidelines and eligibility criteria!

Please click here to register for the TSANZSRS Education Hub!

Respirology – Editor’s Choice

Respirology Issue 27.8 August 2022

Inhalational Exposures in Patients with Fibrotic Interstitial Lung Disease: Presentation, Pulmonary Function, and Survival in the Canadian Registry for Pulmonary Fibrosis

Cathryn T. Lee,Mary E. Strek,Ayodeji Adegunsoye,Alyson W. Wong,Deborah Assayag,Gerard Cox,Charlene D. Fell,Jolene H. Fisher,Andrea S. Gershon,Andrew J. Halayko,Nathan Hambly,Nasreen Khalil,Martin Kolb,Stacey D. Lok,Hélène Manganas,Veronica Marcoux,Julie Morisset,Mohsen Sadatsafavi,Shane Shapera,Teresa To,Pearce Wilcox,Christopher J. Ryerson,Kerri A. Johannson

DOI: 10.1111/resp.14267

 

External Grant Opportunities

European Lung Foundation Healthy Lungs for Life Grants

European Lung Foundation (ELF) is offering grants to support Healthy Lungs for Life activities.

Not-for-profit organisations, patient groups and healthcare professionals can apply for a grant of up to €1,000 to support events and activities that meet one or more of the aims of the Healthy Lungs for Life campaign:

Increase knowledge of the impact of poor air quality on lung health and the actions that everyone can take to reduce air pollution and avoid exposure
Highlight the benefits of quitting smoking
Increase knowledge of the importance of physical activity for lung health
Raise awareness of vaccination to prevent lung infections
This year we also strongly welcome applications linked to the topic of climate change and lung health.

Applications are now open for events focused on World Lung Day and awareness days later in 2022. The closing date for applications is 31 July 2022. To find out more and apply please follow this link.

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

Perspectives on Telehealth for the care of patients with Interstitial Lung Disease (ILD)

We are recruiting health professionals who are involved in the care of patients with Interstitial lung disease (ILD) to participate in this research project. Telehealth for ILD provides an opportunity to improve access to healthcare for patients. Its use has rapidly increased during the COVID-19 pandemic, however there is still a high level of dissatisfaction with telehealth amongst both patients with ILD and healthcare professionals. This study will help us to understand the opinions and experiences of patients with ILD, their caregivers and health professionals of using telehealth in the management of ILD, and ways in which the model can be improved.

Participation in the study will involve taking part in one interview, either in person, over the phone or via zoom. If you are interested in participating or would like further information on this study, please contact:
Dr Sheetal Deshpande
Phone: 03 9903 0214
Email: sheetal.deshpande1@monash.edu

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

Climate Change and Health – WA Healthcare Professionals Survey

The University of Western Australia and Department of Health WA are interested in your views on climate change and health. The information gathered through this project will be used to develop public health messaging and resources for both community and health professionals.

All WA healthcare professionals and healthcare workers with direct client or patient care contact are encouraged to participate. The survey is open from 18 July 2022 to 15 August 2022 and can be accessed online at https://consultation.health.wa.gov.au/pahd-sdu/climate-change-and-health/, and will take approximately fifteen minutes to complete.

Queries can be directed to Sarah Joyce at the Western Australia Department of Health, via email at sarah.joyce@health.wa.gov.au, or by phone on (08) 9222 4017.

LFA COVID-19 Survey

Lung Foundation Australia (LFA) are currently running a survey to gain an understanding of how COVID-19 has impacted Australians and what healthcare, information and support may be needed to help people manage ongoing symptoms. If you’ve had COVID-19 or cared for someone who has, LFA would love to hear your experience by completing this 5-10 minute survey. Completing the survey will put you in the running to win a $150 Visa gift card!

Even if you haven’t had COVID-19, you can share your experience on the government response during the pandemic and the impact of the pandemic on your access to healthcare.

Webinars and Seminars

RACP COVID-19

The RACP COVID-19 Expert Reference Group invites you to attend the upcoming July COVID webinar series.

The RACP have hosted a number of COVID-19 webinar series over the past couple of years in order to inform doctors about important COVID-19 matters, discuss key information and share learnings. We have a great line-up of panellists detailed below and are looking forward to some really engaging discussions.

Please register via the link to attend: REGISTRATION LINK

CALL FOR WEBINAR QUESTIONS – 28 JULY

Do you have any burning questions that you would like us to ask at the webinars? Please send them through to COVIDERG@racp.edu.au.

COVID-19: Where to now?

Thursday 28 July, 6pm-7.30pm AEST / 8pm-9.30pm NZST

This webinar will provide attendees with an understanding of some of the lessons learned though the COVID-19 pandemic and how they might be applied moving forward. The webinar will be in the format of an open panel discussion to guided questions as well as Q&A from webinar attendees.

Hosted by:
Dr Susan Graham, rehabilitation physician and Chair of the RACP COVID-19 Expert Reference Group
Associate Professor Asha Bowen, Head, Skin Health Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute and member of the RACP COVID-19 Expert Reference Group

Expert panellists include:
Professor Paul Kelly, Chief Medical Officer, Department of Health
Professor Christopher Blyth, Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Paediatric Infectious Diseases Physician and Clinical Microbiologist
Professor John Massie, Respiratory Physician and Clinical Director, Children’s Bioethics Centre, Royal Children’s Hospital
Dr Paresh Dawda, General Practitioner, Director and Principal Prestantia Health and Next Practice Canberra
Helen Kulas, NSW Respiratory Network Manager
Professor Peter Wark, Senior Staff Specialist – Respiratory and Sleep Medicine, John Hunter Hospital; Co-Chair NSW Respiratory Network

ACTnet TB Genomics Seminar

Whole genome sequencing of Mycobacterium tuberculsosis is increasingly being
implemented for antimicrobial resistance prediction and transmission surveillance. Join us as our expert panellists discuss the application of this technology for TB control.

When: 3rd August 2022
Time: 1200pm-1330pm (AEST)
Register: Here

Speakers

Dr Chris Coulter, QLD MRL – Topic: Introduction TB to Genomics
Dr Chris Coulter is a Microbiologist, the Chair of TB Expert Advisory Group for Tuberculosis in Queensland, and the Director of the Queensland Mycobacterium Reference Laboratory

Dr Norelle Sherry – Topic: Implementation of TB Genomics for Antimicriobial Resistance Prediction and Public Health
Dr Norelle Sherry is an Infectious Diseases Physician & Clinical Microbiologist, co-appointed at MDU-PHL and Austin Health, with a special interest in antimicrobial resistance (AMR). She is also a clinician-researcher, investigating the use of genomics for surveillance of antimicrobial resistance in multiple different settings, and translation of genomics from the research lab into clinical use.

Prof Vitali Sintchenko – Topic: Case Studies in TB Genomics
Professor Vitali Sintchenko is a leading public health microbiologist and informatician who conducts research on biosurveillance of communicable diseases. He is a Fellow of the Royal College of Pathologists of Australasia and the Australian College of Health Informatics. As the Director of CIDM-Public Health (a translational research hub funded by NSW Health), he leads a public health and diagnostic microbiology team working toward improving laboratory and epidemiological. investigations of communicable diseases.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 5.06 – SEPTEMBER 2020

Research Roundup:

September 2020

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. We hope that you remain well during this difficult time, and our thoughts are especially with our Victorian members who are on the front-line treating patients with COVID or facing unprecedented restrictions.

Plans for our exciting first virtual ASM in 2021 are well underway, with abstract submissions opened on 21 September 2020 and registrations opening on 22 October 2020. Please visit our TSANZSRS2021 website for more details about abstracts, and pay close attention to the closing date of 6 November 2020. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to be resubmitted for the 2021 Annual Scientific Meeting, and all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

The TSANZ Webinar Series continue, with the Society Medal and 50th Anniversary Medalpresentations on 30 September, so don’t forget to register for these exciting events.  

Please also note the opening of the following awards that are now accessible on the TSANZ Awards Submission Portal:

  • Past Presidents Scholarship Award: this new award will support national or international travel costs to present research for early career researchers who do not have the resources available to them via their institution or workplace. Importantly, the awardee will have the support from a TSANZ Past President who will provide invaluable feedback and professional development guidance to help them develop their research presentation skills.
  • Boehringer Ingelheim New Zealand Primary Care Grant: this award addresses the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.

In addition, we are pleased to announce the new CREATE PhD Scholarship, and the opening of LFA Awards:

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the September edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Call for Abstracts

Abstracts for TSANZSRS21 are now open. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to resubmit for the 2021 Annual Scientific Meeting. Please note, all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

Please submit your abstract by 6 November and join us for our first ever virtual ASM in 2021!

 

New Award: CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis

The CREATE PhD Scholarships in Pulmonary Fibrosis will support research into pulmonary fibrosis in Australia

Relevant domains of research inquiry include any form of clinical, population, laboratory, genetic or tissue based research. 

Students who are wishing to undertake a PhD, or are currently enrolled in a PhD in Pulmonary Fibrosis Research, are invited to submit an application. The student must be a resident in Australia throughout the period of the research program.

The Centre of Research Excellence in Pulmonary Fibrosis (the CRE-PF)  will allocate a total of two grants, each of $28,000, for the PhD Scholarships. These scholarships will either fund a stipend for one year for a full time student or may be extended over a second year, should the student be able to secure matching funds to permit extension of the period via their University or Research Institute. Extension of the funding in order to extend the value of the research investment by the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) and Lung Foundation Australia by securing matching funding from the host institution is encouraged and will be regarded favourably.

These funds are to be used for the student stipend. Direct, indirect research costs and/or infrastructure costs do not form part of this grant and will not be covered by this funding.

Click here for more info!

Open Awards

Thoracic Society Awards

TSANZ Past Presidents Scholarship Award – closing 04 October 2020

Boehringer Ingelheim New Zealand Primary Care Grant – closing 04 October 2020

TSANZ ASM 2021 abstract-linked Awards – closing 6 November 2020

 Lung Foundation Awards

Lizotte Family Idiopathic Pulmonary Fibrosis Research Grant – closing 13 October 2020

Ludwig Engel Grant-in-Aid for Physiological Respiratory Research – closing 13 October 2020

Ivan Cash Grant-in-Aid For Idiopathic Pulmonary Fibrosis Research – closing 13 October 2020

Cochrane Airways Australia Scholarship – closing 13 October 2020

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)

CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis – closing 31 October 2020

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Special Issue and Editor’s Choice
 

Respirology Issue 25.9 September 2020

 

Special Issue: Interventional Pulmonology Pearls

 

Cover caption: A collection of images from the Invited review series International Pumlonology Pearls.

Illustrations credit (A to F clockwise from top left) : A and B: Pyng Lee (personal communication), C and D: Fielding and Oki p.914, E: Guibert et al. p.953, F: Shah and Slebos p.972.

DOI: 10.1111/resp.13598

 

Respirology Issue 25.10 October 2020

 

Acute effects of e-cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma

Serafeim-Chrysovalantis Kotoulas, Athanasia Pataka, Kallipoi Domvri, Dionisios Sypratos, Paraskevi Katsaounou, Konstantinos Porpodis, Evangelia Fouka, Aikaterini Markopoulou, Katalin Passa-Fekte, Ioanna Grigoriou, Theodoros Kontakiotis, Paraskevi Argyropoulou and Despoina Papakosta

 

Cover caption: Asthmatic and healthy smokers underwent pulmonary function tests to assess acute effects of e-cigarettes

DOI: 10.1111/resp.13806

 

Peer Connect Service for people with pulmonary fibrosis in Australia: Participants’ experiences and process evaluation

Gabriella Tikellis, Joanna Y.T. Lee, Tamera J. Corte, Jamie Maloney, Michael Bartlett, Tonia Crawford, Ian N. Glaspole, Nicole Goh, Kelcie Herrmann, Alison J. Hey-Cunningham, Greg Keir, Yet H. Khor, John Price, Debra G. Sandford, Lissa Spencer, Alan Teoh, Jennifer Walsh, Susanne Webster and Anne E. Holland

 

Cover caption:  Bill, diagnosed with IPF in 2015, is a primary peer within the Pulmonary Fibrosis Peer Connect service. (Photograph credit: Lung Foundation Australia)

DOI: 10.1111/resp.13807

Invitations and surveys

BREATHE Study

Do you have asthma, emphysema, chronic bronchitis or bronchiectasis?

Do you live in an area affected by bushfires or bushfire smoke?

If yes to both, you may be eligible for the BREATHE study.

We are studying facemasks for prevention of smoke exposure

Find out more: https://kirby.unsw.edu.au/breathe

Please register your interest: https://www.surveymonkey.com/r/C96DXJN

Contact us: e.kpozehouen@unsw.edu.au

Ethics Approval: HC200477

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

 

VOLUME 7.06 – JULY 2022

VOLUME 5.05 – AUGUST 2020

Research Roundup:

August 2020

.

Welcome Message

Welcome to the August Research Roundup. We hope you are all staying well in these uneasy COVID-19 times.

This month we are pleased to open two new awards. Firstly, we are very excited to announce and gratefully acknowledge the generous donation from our immediate past president, Prof Allan Glanville, to establish the Past Presidents Scholarship Award. We hope that others will join him in supporting this award that will provide both funding for our ECRs and, provide access to professional mentors and networks. Given global travel restrictions, ECRs are encouraged to think creatively when applying and consider the merit in visiting institutions closer to home.

Secondly, we would like to thank Boehringer Ingelheim New Zealand for supporting a new award for our New Zealand members. The Boehringer Ingelheim New Zealand Primary Care Grant aims to support research which will address the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic. Primary care can include general practice, allied health services, community health and community pharmacy.

As you would be aware, TSANZ is part of the National COVID-19 Clinical Evidence Taskforce; a living guideline which is continuously updated as new peer reviewed research becomes available. Many of our members are contributing to the COVID-19 research effort. One large multi-centre trial is the ASCOT trial (AustralaSian COVID-19 Trial) which many of our members are involved in. This trial will which be featured in a TSANZ webinar on 17 September 20.

We are pleased to again be hosting the LFA Awards. These will be opening on the 1st of September, including the Lizotte Family Research Award for IPF Research; Ludwig Engel Grant-in-Aid for Physiological Research; Ivan Cash Grant-in-Aid for IPF Research; and the Cochrane Airways Australia Scholarship. Please see below for more details.

As TSANZ members we also have the privilege of participating in an increasing number of surveys as detailed below. These include surveys of the Breathe Study: Investigating the role of masks for patients with asthma and COPD against bushfire smoke, Cystic Fibrosis Australia Research and Advocacy Priority Setting, and studies aimed at improving the quality of clinical trials evaluating  the management of COPD exacerbations, nurses’ attitudes to caring for people with intellectual disability, global current practices of mechanical ventilation management in COVID-19 patients, self-management for pulmonary fibrosis and  identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of PF. These are all very worthy studies and we encourage your participation.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the August edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

TSANZ Past President’s Award

The TSANZ Past Presidents Scholarship Award aims to support early career researchers (ECRs) who do not have the resources available to them via their institution or workplace to:

1)  Develop their presentation of research skills, and/or

2) Present their research at a national or international professional conference of their choice.

The Scholarship will cover

  • Airfares
  • Accommodation
  • Ground travel and transfers
  • Registration
  • Per Diem Daily Allowance in accordance with the ATO Reasonable Travel and Meal Allowance Guide

Up to a maximum of AUD 7000, with the amount to be paid dependent on the delivery of receipts for the expenses incurred above.

Additionally, the Scholarship will provide the awardee with support from a TSANZ Past President to review their presentation and provide feedback and professional development on research presentation skills. The Past President will be determined by TSANZ.

Please visit the TSANZ Awards Submissions Portal for more information.

Boeringer Ingelheim New Zealand Primary Care Grant

The Boehringer Ingelheim New Zealand Primary Care Grant aims to support research which will address the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.

Primary care can include general practice, allied health services, community health and community pharmacy.

The grant is valued at NZD 5000 and will support studies for one year only.

Please visit the TSANZ Awards Submissions Portal for more information.

CREATE Grant-in-Aid Funding Opportunity

In 2020, there is a CREATE Grant-in-Aid opportunity for the award of one or more grants valued at a total of $7,000 to assist new collaborative investigator led Pulmonary Fibrosis research within the group of CREATE Fellows. The objective of the CREATE Grant-in-Aid is to encourage new research which meets the aims of the CRE-PF and builds collaborations between CREATE Fellows drawn together through the CRE-PF.

Please visit the LFA Awards Submissions Portal for more information.

LFA Awards

Lung Foundation Australia and its partners are excited to announce the following Research Grants will be open to application from 1 September 2020. For more information visit: https://lungfoundation.com.au/research/awards-and-grants/apply-for-funding/

YEAR OPEN

YEAR UNDERTAKEN

Award 

Target area 

Value

Duration

Timeline

2020

2021

Lung Foundation Australia – Lizotte Family Grant for IPF Research 

IPF 

 $        5,000.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

2020

2021

Lung Foundation Australia – Ludwig Engel Grant-in-Aid for Physiological Respiratory Research

IPF 

 $        5,000.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

2020

2021

Lung Foundation Australia -Ivan Cash Grant-in-Aid For IPF Research

IPF 

 $        5,000.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

2020

2021

Lung Foundation Australia -Cochrane Airways Australia 
Scholarship

Systematic Review

$        2,500.00 

1 year

1 September 2020 (close 13 October, announced 11 Dec) 

 

LFA 2020 Research Grant recipients

 

Congratulations to the recipients of the Lung Foundation Australia 2020 Research Grants.

2019

2020

Lung Foundation Australia – Ellen Yates Memorial Grant in Aid for Lung Cancer Research

$20,000.00 

Edith Cowan University

Dr. Afaf Abed

2019

2020

Lung Foundation Australia – Deep Manchanda Fellowship in Lung Cancer Research

$   160,000.00 

The Garvan Institute of Medical Research

Dr. Venessa Chin

2019

2020

Lung Foundation Australia – Di Cox PhD Scholarship in IPF Research 

 $      45,000.00 

 University of Sydney

Dr. Laura Glenn

2019

2020

Lung Foundation Australia – Brian Eaton PhD Scholarship in IPF Research 

 $      45,000.00 

 University of Sydney

Dr. Matthew Parker

2019

2020

Lung Foundation Australia – Lizotte Family Grant for IPF Research

$        5,000.00 

Austin Health

Dr Yet Hong Khor

2019

2020

Lung Foundation Australia – Ludwig Engel Grant-in-Aid for Physiological Respiratory Research

$        5,000.00 

The Children’s Hospital at Westmead

Dr. Alexander Wong 

2019

2020

Lung Foundation Australia – Ivan Cash Grant-in-Aid For IPF Research

$        5,000.00 

RMIT University 

Dr. Paris Papagianis

2019

2020

Lung Foundation Australia – Cochrane Airways Australia 
Scholarship

$        2,500.00 

University of South Australia

Kelsey Sharrad

 

Australasian Severe Asthma Registry (ASAR) Annual Report 2019

 

TSANZ is excited to share the ASAR 2019 Annual Report with you!

In 2019, TSANZ in collaboration with the Australasian Severe Asthma Network (ASAN), successfully transitioned the Severe Asthma Web-based Database (SAWD) to ASAR – a Clinical Quality Registry (CQR). ASAR is now uniquely positioned to collect longitudinal data (10-year follow-up) on a well-characterised severe asthma cohort in Australia and New Zealand with the capability to add modules of specific interest, for example, the Australasian Benralizumab Registry.

To view the ASAR 2019 Annual Report please click here.

Respirology – Editor’s Choice 

Respirology Issue 25.7 July 2020

 

Sputum transcriptomics implicates increased p38 signalling activity in severe asthma

Katherine J. Baines, Michael Fricker, Vanessa M. McDonald, Jodie L. Simpson, Lisa G. Wood, Peter A.B. Warik, Heather E. Macdonald, Andrew Reid and Peter G. Gibson

 

The authorship team from Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia

DOI: 10.1111/resp.13749

 

Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study

Hye Yun Park, Danbee Kang, Hyun Lee, Sun Hye Shin, Minwoong Kang, Sunga Kong, Chin Kook Rhee, Juhee Cho and Kwang Ha Yoo

 

The Korean COPD And Outcomes Study Team. From left to right: (Top) Kwang Ha Yoo, Danbee Kang, Sun Hye Shin, (Bottom) Juhee Cho and Hye Yun Park

DOI: 10.1111/resp.13678

Respirology Issue 25.8 August 2020

 

Ventilation heterogeneity and oscillometry predict asthma control improvement following step-up inhaled therapy in uncontrolled asthma

Francesca S.M. Tang, Sandra Rutting, Catherine E. Farrow, Katrina O. Tonga, Joanna Watts, Jessica R. Dame-Carrol, Amy Bertolin, Gregory G. King, Cindy Thamrin and David G. Chapman

 

The Airway Physiology and Imaging Group from the Woolcock Institute of Medical Research in Sydney, Australia, as part of the overall research team. From left to right: Prof. Gregory King, Dr David Chapman, Dr Sandra Rutting, Dr Katrina Tonga and A/Prof. Cindy Thamrin.

DOI: 10.1111/resp.13772

 

Identification and definition of asthma–COPD overlap: The CanCOLD study

Miriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, Wan C. Tan, Pei Z. Li, Shawn D. Aaron, Andrea Benedetti, Kenneth R. Chapman, Brandie Walker, J. Mark Fitzgerald, Paul Hernandez, François Maltais, Darcy D. Marciniuk, Denis E. O’Donnell, Don D. Sin, Jean Bourbeau for The Cancold Collaborative Research Group and The Canadian Respiratory Research Network

 

The authorship team on behalf of the CanCOLD Collaborative Research Group and

the Canadian Respiratory Research Network. From top left to right bottom: Miriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, Wan Tan, Pei Li, Shawn Aaron, Andrea Benedetti, Kenneth Chapman, B Walker, Mark Fitzgerald, Paul Hernandez, François Maltais, Darcy Marciniuk, Denis O’Donnell, Don Sin, Jean Bourbeau

DOI: 10.1111/resp.13780

Invitations and surveys

BREATHE Study

Do you have asthma, emphysema, chronic bronchitis or bronchiectasis?

Do you live in an area affected by bushfires or bushfire smoke?

If yes to both, you may be eligible for the BREATHE study.

We are studying facemasks for prevention of smoke exposure

Find out more: https://kirby.unsw.edu.au/breathe

Please register your interest: https://www.surveymonkey.com/r/C96DXJN

Contact us: e.kpozehouen@unsw.edu.au

Ethics Approval: HC200477

CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

Dear Members of the Thoracic Society of Australia and New Zealand,

Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

https://www.surveymonkey.com/r/F38Q8K2

We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

 

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

Dear Colleagues,

We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

Caring for People with Intellectual Disability survey

Thank you for considering our invitation
A/Prof Nathan Wilson, Western Sydney University
Dr Peter Lewis, Western Sydney University
Ms Virginia Howie, Central Queensland University
Dr Melissa Desroches, University of Massachusetts, Dartmouth

Kind regards,
Virginia

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

 

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland
Professor of Physiotherapy, Monash University and Alfred Health
Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 5.02 – MARCH 2020

Research Roundup:

March 2020

.

Welcome Message

By now I’m sure you’ve heard that TSANZSRS 2020 has been postponed until 29 April – 4 May 2021. The TSANZ Board released a letter and FAQ outlining this decision on 12 March 2020.

The Board is busy working through all the issues that have arisen from this decision and we will be in touch with updates as they happen. Whilst the the Research Sub-Committee has finalised most awards, we are now looking at how to publicly acknowledge 2020 award recipients. 

COVID-19

Infectious diseases research is a significant area of strength in Australia and the TSANZ acknowledges the important work of our Australian researchers who are international leaders in research surrounding COVID-19. Examples include the creation of the vaccine candidate for COVID-19 by the University of Queensland – achieved in just three weeks! Scientists at CSIRO’s state-of-the-art biologics production facility in Melbourne have already begun small-scale testing. Doherty Institute researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection (published in Nature) while CSIRO’s research aims to get a better understanding of the virus – how long it takes to develop and replicate, how it impacts the respiratory system and how it can be transmitted. 

We also acknowledge the support of the Australian Government that will invest $30 million for COVID-19 research to enable Australian researchers to contribute to global efforts to control the outbreak. In addition, NHMRC recognises that the COVID-19 pandemic may be affecting the research of current grant holders. If you have received a grant and circumstances have changed – for example, there has been a delay in your Research Activity because of involvement in the clinical or public health response – you can apply to vary your grant. Variations that may be relevant due to the impact of COVID-19 include: Deferral of commencement date and requests for grants applications, deferral of an in-progress grant and extended leave requests, extended end date, change to a research plan or change to chief investigators. For more information please visit: https://www.nhmrc.gov.au/funding/manage-your-funding/vary-your-grant.

TSANZ are collaborating to support the Australian Living Evidence Consortium who, with Cochrane Australia are working to develop a National COVID-19 Clinical Evidence Taskforce. There is a survey below which will help to determine high-priority clinical questions and a request for EOIs to join the guideline panel. I encourage all interested parties to contribute to this work through the article below.

We wish you all the best in your work and in preparation of your grant applications.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

National COVID-19 Clinical Evidence Taskforce

Dear colleague,

The Australian Living Evidence Consortium and Cochrane Australia are working with others to support the development of a National COVID-19 Clinical Evidence Taskforce. As part of this we are working with peak professional bodies to develop living, evidence-informed guidance for primary, hospital and critical care of adults and children with suspected or confirmed COVID-19 infection. Guidance will be updated weekly as new evidence emerges.

We would like your suggestions for high-priority clinical questions to be addressed by this guidance.

Please suggest questions by completing the form at https://forms.gle/SDS9t2tMhiHvnRoPA by 9pm Sunday March 22.

We are also seeking interested clinicians to join guideline panels. These will initially be convened next week, and then meet regularly over the next weeks and months to review emerging evidence and refine the recommendations. To express your interest in membership in a guideline panel, please email your CV to Dr Britta Tendal, Senior Research Fellow at Cochrane Australia at britta.tendal@monash.edu by 9pm Sunday March 22. 

If you have any queries please contact Dr Tari Turner, Senior Research Fellow at Cochrane Australia at tari.turner@monash.edu

Thank you

Respirology – Editor’s Choice 

Respirology Issue 25.3 March 2020

 

Global Lung Function Initiative‐2012 ‘other/mixed’ spirometry reference equation provides the best overall fit for Australian Aboriginal and/or Torres Strait Islander children and young adults

Tamara L. Blake, Anne B. Chang, Mark D. Chatfield, Julie M. Marchant and Margaret S. McElrea

 

DOI: 10.1111/resp.13649

Study participant from Thursday Island performing spirometry (with permission by the Queensland Government)

 

Association of serious adverse events with Cheyne–Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis

Faizan Javed, Renaud Tamisier, Jean-Louis Pepin, Martin R. Cowie, Karl Wegscheider, Christiane Angermann, Marie-Pia D’ortho, Erland Erdmann, Anita K. Simonds, Virend K. Somers, Helmut Teschler, Patrick Levy, Jeff Armitstead and Holger Woehrle

 

 Schematic representation of CheyneStokes respiration signal.

DOI: 10.1111/resp.13613

Invitation

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland

Professor of Physiotherapy, Monash University and Alfred Health

Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University

Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 7.06 – JULY 2022

VOLUME 5.01 – FEBRUARY 2020

Research Roundup:

February 2020

.
 

Welcome Message

Welcome to the first Research Roundup of 2020. The Research Sub-Committee are currently working their way through reviewing the many award applications received in the last few months. 

The TSANZSRS20 is less than 2 months away. This year’s theme is “Transformative Strategies for Improving Global Lung Health”. Visit the conference website for the full program or to register now

For the first time, the TSANZ will be offering a Carer’s Grant as part of the TSANZ travel award program to assist members who have the primary care giver responsibility of a child to attend and participate in the TSANZ ASM.

We wish you all the best in your work and in preparation of your grant applications.

Enjoy the February edition of your research roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

TSANZ ASM Carer’s Grant

 

TSANZ is committed to inclusion and diversity in all that we do. The TSANZ ASM Carer’s Grant is provided, as part of the TSANZ travel award program, to support TSANZ members who have primary care giver responsibility of a child financial assistance to attend and participate in the TSANZ Annual Scientific Meeting. The grant must be utilised to fund additional care giving costs incurred directly as a result of the caregiver’s participation in the ASM. The grant must not be used for existing care costs or to cover the usual costs of attendance such as travel expenses and conference registration.

Selection process: If more applicants are received than funds available, the TSANZ will, in their absolute discretion, determine how the funds will be allocated. Priority will be given to applicants with children up to primary school age or children of any age with special needs.

Closing date: Friday 28 February 2020

Note: Receipts will not be required until money is claimed after the event.

For more information click here.

Respirology – Editor’s Choice 

Respirology Issue 25.2 February 2019

 

Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand

Lianne Parkin, Joshua Quon, Katrina Sharples, David Barson AND Jack Dummer

 

 

DOI: 10.1111/resp.13662

 

Improved diagnostic yield for lung nodules with digital tomosynthesis-corrected navigational bronchoscopy: Initial experience with a novel adjunct

Matt Aboudara, Lance Roller, Otis Rickman, Robert J. Lentz, Jasleen Pannu, Heidi Chen, ​​​​​​​Fabien Maldonado

 

Researchers from The Vanderbilt University Medical Center, Nashville, TN, and The Ohio State University Wexner Medical Center, Columbus, OH, USA. Left to Right:  Robert Lentz, M.D., Fabien Maldonado, M.D., Charla Walston, NP, Jasleen Pannu, M.D., Matt Aboudara, M.D., and Otis Rickman, D.O.  (Missing:  Lance Roller and Heidi Chen)

DOI: 10.1111/resp.13609

Workshops and Conferences

 

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 7.06 – JULY 2022

VOLUME 4.010 – DECEMBER 2019

Research Roundup:

December 2019

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have three awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS 2020!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Editor’s Choice 

Respirology Issue 24.12 December 2019

 

Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD

Mette Reilev, Anton Pottegård, Jesper Lykkegaard, Jens Søndergaard, Truls S Ingebrigtsen and Jesper Hallas

 

 

DOI: 10.1111/resp.13620

Top row, from left to right: Mette Reilev, Jesper Hallas and Anton Pottegård, Clinical Pharmacology and Pharmacy, University of Southern Denmark

Bottom row, from left to right: Jesper Lykkegaard and Jens Søndergaard, The Research Unit for General Practice, University of Southern Denmark

Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial

Maree A. Milross, Amanda J. Piper, Tiffany J. Dwyer, Keith Wong, Scott C. Bell, Peter T.P. Bye and the Non-Invasive Ventilation Cystic Fibrosis (NIVCF) Study Group

Non-invasive ventilation in cystic fibrosis

DOI: 10.1111/resp.13604

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

 

Chronic Breathlessness

 

The Australian national Palliative Care Clinical Studies Collaborative (PaCCSC) is pleased to announce the publication of results from a recently completed multi-site, double-blind, randomised controlled trial that found that regular, sustained-release morphine had similar benefits and harms to placebo in this adequately powered trial at one week.

The manuscript is titled “Regular, sustained-release morphine for chronic breathlessness: a multi-centre, double-blind, randomised, placebo controlled trial”. Authored by David Currow and colleagues, the paper was published in Thorax 2019; 213681 (ahead of print). A copy of the paper is attached for your benefit.

 

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 7.06 – JULY 2022

VOLUME 4.09 NOVEMBER 2019

Research Roundup:

November 2019

.
 

Welcome Message

We are now in the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Sub-committee is in full swing reviewing award applications, the SIG convenors are reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2020, we are expecting another large conference, having received approximately 440 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2020.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

Lund Foundation Australia Research Awards 

  • Cochrane Airways Australia Scholarship – extended to 15 November 2019

To download application documents, click here.

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

TSANZ Webinar Series

 

“Tracheostomy tubes and principles of management” with Gavin Fahey

Event Date: Thursday, 14th of November 2019

Time: 2:30pm AEDT

Duration: 45 minutes

A presentation covering anatomy and physiology, tube selection, principles of nursing and emergency management.

Only limited places available! Don’t miss out!

The presenter: Gavin Fahey

Gavin Fahey currently works as Senior Respiratory Clinical Nurse Consultant (CNC) at Northern Health (NH) leading a team of Respiratory CNCs who since 2018 have collectively contributed to acquisition and management of oxygen services across NH, development of a 4-bed Respiratory Care Unit caring for patients with severe respiratory failure, and improving lung mass services incorporating development of Victoria’s first Specialist Ambulatory Pleural Service. Gavin’s experience includes working within both the Victorian Respiratory Support Service and Tracheostomy and Management Service (Austin Health) utilising his experience and advanced understanding of tracheostomy and ventilation management within the acute and outpatients setting.

CLICK HERE to register! 

_______________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 24.11 November 2019

Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial

Steven McKinstry, Joseph Singer, Jan Pieter Baarsma, Mark Weatherall, Richard Beasley, James Fingleton

DOI: 10.1111/resp.13575

Nasal High Flow therapy in use

BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo

Rebecca L. Harper, Suzanne Maiolo, Rebekah J. Ward, Jemma Seyfang, Michaelia P. Cockshell, Claudine S. Bonder, Paul N. Reynolds

Putative mechanism of cell therapy upregulating BMPR2 in pulmonary vessels via release of exosomes

DOI: 10.1111/resp.13552

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

Dear TSANZ Members,

Lung Foundation Australia, with the support of nursing members of the Australia and New Zealand – Lung Cancer Nurse Forum, invite you to the next workshop in the series: Treatment Modalities and Management of a Stage 3 NSCLC Patient workshop, in Hobart on Friday 29 November 2019.

These workshops are open to nurses and allied health with an interest in working with and caring for people with lung cancer.

Date: Friday 29 November 2019

Time: 9:30am – 12:30pm

Location: Cancer Support Centre, Royal Hobart Hospital, 48 Liverpool St, Hobart TAS 7000

Program: Medical experts including nurses, medical oncology and radiation oncology specialists, and allied health professionals will discuss the management of a Stage III unresectable lung cancer patient.

More information about the agenda and speakers are coming soon. Please see our website for up to date information on this workshop.

Workshops are free to attend and you will be provided with a certificate for your hours of learning.

Register here

Please RSVP by Friday 22 November 2019. Registrations are essential for seating and catering purposes. For more information on the event, please visit our website here.

For further queries, please contact our information and support centre freecall on 1800 654 301 or email enquiries@lungfoundation.com.au.

We hope to see you on the day!

Kind Regards,

Lung Foundation Australia

 

                                                                                                                                                              

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 7.06 – JULY 2022

VOLUME 3.08 NOVEMBER 2018

Research Roundup:

November 2018

.
 

Welcome Message

We are now well into the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Subcommittee is in full swing reviewing award applications, the SIG convenors are busy reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2019 we are expecting another large conference, having received approximately 400 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2019.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

Finally, here is an open invitation for TSANZ members who would like to share their Research Story with us. We have been working with The limbic for nearly three years now to bring you the latest research media in our research roundup. Part of this roundup occasionally features TSANZ members and their “holy grail”. This section will also feature on the limbic’s respiratory news website and be visible to other subscribers. If you would like to share your holy grail, please tell us a little bit about yourself here.

Enjoy the November edition of your research roundup and please check out the surveys below!

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

Research and Career Development Awards

Maurice Blackburn ASM Travel Award extended –  closes 3 Dec 18

Boehringer Ingelheim COPD Research Award – closes 3 Dec 18

TSANZ Indigenous Respiratory Nursing Award – reopened – closes 3 Dec 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency extended –  closes 3 Dec 18

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

TSANZ Webinar Series

“What’s in a cough? Implications for the care of people with flu and MROs” with Professor Scott Bell

Event Date: Tuesday, 27th November 2018

Time: 2pm – 3pm AEDT

Duration: 45 minutes

The CF-Air Research Program has provided novel data regarding the prevalence of shared strain infection in CF, potential acquisition pathways including from the natural environment and via direct person-to-person spread of bacteria. This was possible due to the establishment of a multi-disciplinary research team to support studies of the mechanism of cross-infection using CF as a model. Our current work focusses on other CF pathogens and origins and acquisition pathways including Mycobacterium and the potential spread of infection amongst patients with non-CF lung diseases. We have evaluated cough aerosols are highly innovative as no such equipment has been replicated to date, providing in vivo cough studies, safely delivered to patients with respiratory infections.

Only limited places available! Don’t miss out!

The presenter: Professor Scott Bell

Professor Scott Bell is Executive Director – Research, MNHHS and a Senior Physician of the Adult Cystic Fibrosis Centre at TPCH (>320 patients) where he has worked since 1996. He is currently the Editor-in-Chief of the Journal of Cystic Fibrosis. He leads the Lung Bacteria Laboratory at QIMR Berghofer Medical Research Institute in Brisbane. Scott has over 200 peer reviewed publications and has received grant support in excess of $12 million over the past 10 years. His research interests include the CF microbiology, acquisition pathways for human infection and has a long history of supporting multi-disciplinary research. He has been PI on numerous pivotal CFTR modulator trials and is global PI on a novel approach to combination therapies for CFTR correction.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 23.11 (November 2018)

Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD

Floor J. Hartjes, Judith M. Vonk, Alen Faiz, Pieter S. Hiemstra, Thérèse S. Lapperre, Huib A.M. Kerstjens, Dirkje S. Postma, Maarten van den Berge and the Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group

DOI: 10.1111/resp.13312

 

               Groningen Research Institute for Asthma and COPD (GRIAC), The Netherlands.

Multidimensional improvement in connective tissue disease associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus

Yasuhiko Yamano, Hiroyuki Taniguchi, Yasuhiro Kondoh, Masahiko Ando, Kensuke Kataoka, ​​​​​​​Taiki Furukawa, Takeshi Johkoh, Junya Fukuoka, Koji Sakamoto, Yoshinori Hasegawa

DOI: 10.1111/resp.13365

 

Research team at Department of Respiratory Medicine and Allergy at Tosei General Hospital in Seto, Japan.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach concensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 

.

VOLUME 7.06 – JULY 2022

VOLUME 3.07 OCTOBER 2018

Research Roundup:

October 2018

.
 

Welcome Message

Welcome to October – a busy month for awards as the first wave of awards close and the second wave of awards open. We are pleased to announce that the Boehringer Ingelheim COPD Research Award is now open, and the Boehringer Ingelheim Australia COPD Travel Award and Boehringer Ingelheim New Zealand COPD Travel Award have been added to the TSANZSRS2019 abstract submission portal.

Don’t forget that Abstract-linked awards are closing soon! (this Friday!) Apply now for some of the many abstract-linked awards and, for early career researchers, take the opportunity to present your work to our full membership by entering the Ann Woolcock New Investigator competition.

The full list of awards can be found in the Open Awards section in this newsletter and on the TSANZ Awards web page.

Lastly, please support the research of TSANZ members and supporters by contributing to the surveys at the end of this newsletter.

Enjoy the October edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

Abstract-linked awards

To apply for an abstract-linked award, you must complete the application coversheet using the upload functionality in the online abstract submission portal

Ann Woolcock New Investigator Award

Boehringer Ingelheim COPD Travel Award (AU)

Boehringer Ingelheim COPD Travel Award (NZ)

Janet Elder International Travel Award

Japanese Respiratory Society (JRS) Early Career Development

TSANZ Travel Grants to 2019 ASM

For more information visit http://www.tsanzsrs2019.com/abstracts/tsanz-awards-criteria/

Abstracts close 12 October 2018 6pm AEST

Research and Career Development Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease – closes 18 Nov 18

Maurice Blackburn ASM Travel Award – closes 18 Nov 18

Boehringer Ingelheim COPD Research Award – closes 3 Dec 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

Lung Foundation Australia Awards

The Lung Foundation Australia David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019 – closes 10 Oct 18

Lung Foundation Australia/ Cochrane Airways Australia Scholarship 2019 – closes 2 Nov 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Cystic Fibrosis Innovation Grant

Cystic Fibrosis Australia (CFA) is pleased to announce the 2019 Innovation Grant for post-doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.

The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage.  Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data.  The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research.  The researcher will have completed a research higher degree in CF or a related area within the last ten years.

The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months.  In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

The maximum amount awarded under the Innovation Grant will be $80,000.  The actual amount provided will be subject to approval of the applicant’s budget.

Applications can be made through the website of The Thoracic Society of Australia & New Zealand (TSANZ) and must be received by TSANZ by late January 2019.

Apply Here

TSANZ Webinar Series

Thursday 11th October 2018, 1pm AEDT | 3pm NZDT

Research Techniques to Study Respiratory Diseases – Prof Phil Hansbro

The webinar will be discussing a range of techniques that are valuable for studying disease, identifying new therapeutic targets and testing novel treatments. 

Professor Phil Hansbro Biography:

Professor Hansbro is a group leader and holds a personal chair in immunology and microbiology at the Hunter Medical Research Institute and University of Newcastle, Australia and is Associate Director of the Priority Research Centre for Asthma and Respiratory Diseases there. He is also an NHMRC Principal Research Fellow. He has established internationally recognised research programs in infections, COPD, asthma and recently lung cancer. His group has developed several novel mouse models of the important diseases (COPD, severe, steroid-insensitive asthma, early life infection & lung cancer). He has interrogated them (immune, histological, pathological, lung function & molecular analysis) to substantially further our understanding of pathogenesis and to develop novel therapies. He performs complimentary collaborative clinical and multi-disciplinary studies and collaborates widely. He publishes extensively in influential journals and he is regularly invited to present internationally including as plenary and to chair sessions. He has a substantial funding record of obtaining nationally competitive grants that support his group. He undertakes substantial mentoring and supervision activities of junior researchers, regularly sits on grant review panels and is on the editorial board of 4 journals. He is an active advocate for respiratory research in lobby groups and is regularly in the press promoting research and funding.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars with Professor Allan Glanville and Sally Powell are now available for on-demand viewing. For more information, please CLICK HERE!

Thoracic Society Medals and FThorSoc

Each year the TSANZ invites members to nominate their peers to be considered for a number of prestigious awards, namely: Research Medal, Society Medal and 50th Anniversary Medal for Education & Training. Nominations for these awards are now invited from members of all backgrounds and professions. Recipients of these awards will be presented with their medals at the TSANZSRS 2019 Gala Dinner and Awards Evening.  

Members are also encouraged to consider applying to become a Fellow of TSANZ. Applications for Fellow status are reviewed by the Professional Standards Subcommittee and reviewed and endorsed by the Board. Fellow status is available to members from all professions who demonstrate an exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ. Recipients of the post nominal FThorSoc will be announced at the AGM 2019.

The Research Medal, Society Medal, 50th Anniversary Medal and Fellows of TSANZ are distinctive awards – a testament of the recipients’ exceptional contributions in the field of respiratory health in Australia or New Zealand.

Read below for more details & how to apply/nominate your peers. Closing date: Friday 2nd November 2018

TSANZ Fellowship 

DOWNLOAD APPLICATION FORM

For more information please visit: https://www.thoracic.org.au/about-us/fellow-of-thoracic-society-australia-new-zealand

Background:

The TSANZ Board makes an annual call for nominations for members to be awarded Fellow status. The call is made to members from all professions who demonstrate exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ.

The main aims of the Fellow status are:

  1. To recognise expertise and experience in respiratory medicine and/or research and/or respiratory health service provision.
  2. To acknowledge a major contribution and commitment to advancing respiratory health in Australia and/ or New Zealand.

Requirements for Awarding of FThorSoc:

TSANZ members may apply to become a Fellow of the Thoracic Society of Australia and New Zealand (FThorSoc) if they demonstrate exceptional contribution to 5 of the 7 criteria listed below. For the remaining 2 criteria, the applicant must demonstrate a proven track record.

The criteria are:

  1. A continuous financial member of TSANZ for five consecutive years in Australia and/or New Zealand as well as a minimum of ten years post-specialist qualification
  2. Contribution to advocacy and/or policy development
  3. Service within the community
  4. Distinguished leadership
  5. Contribution to research
  6. Contribution to teaching or training
  7. International recognition in his or her discipline

List of Fellows of The Thoracic Society Australia and New Zealand:

The following individuals have been nominated by their peers, recommended to the Board by the Professional Standards Sub-Committee and formally recognised by the Board for their exceptional contributions to respiratory health in Australia and New Zealand.

FTHORSOC 2013

FTHORSOC 2014

FTHORSOC 2015

FTHORSOC 2016

FTHORSOC 2017 

FTHORSOC 2018 

___________________________________________________________

Awards By Nomination

The Research Medal, Society Medal and 50th Anniversary Medal are awards for distinguished service. Nominations for each of these awards are invited as outlined below. 

 

The Research Medal 

About 

The Research Medal may be awarded each year in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

HOW TO NOMINATE

Candidates

The Research Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Research Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The Society Medal 

About

The Society Medal was conceived as an acknowledgement of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy. The inaugural Society Medal was presented at the annual dinner in Canberra in 1992 to Dr Maurice Joseph, who ably embodied the qualities envisaged by this senior prestigious award.

HOW TO NOMINATE

Candidates

The Society Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Society Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The 50th Anniversary Medal for Education and Training 

About

The 50th Anniversary Medal is an award introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal may be awarded each year in recognition of outstanding contributions to respiratory education and training in New Zealand or Australia. The award recognises an individual who has demonstrated sustained excellence in education and training. This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine.

HOW TO NOMINATE

Candidates

The 50th Anniversary Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved 50th Anniversary Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate. 

Clinical Trials Workshop

The Centre of Excellence is pleased to be hosting a Clinical Trials Workshop on 24 October 2018 from 1 – 4PM at the Hunter Medical Research Institute, Caves Theatre. We believe this session will be of broad interest and would appreciate your support in distributing this invitation as broadly as possible.

We are pleased to confirm 4 experts in the field presenting on:

1:00 – 1:40: Clinical Trials Funding (Prof. Bruce Neal, The George Institute)

1:40 – 2:50: Integrating Public Involvement in Research and Clinical Trials (Prof. William Tarnow-Mordi, NHMRC CTC & Melinda Cruz, Miracle Babies Foundation)

3:20 – 4:00: Designing Implementation Trials (Prof. John Wiggers, University of Newcastle)

An event flyer can be downloaded at: https://www.severeasthma.org.au/wp-content/uploads/2018/09/24Oct2018-Clinical-Trials-Workshop.pdf

Lunch will be served before the event and refreshments during an intermission. Please RSVP your interest for catering purposes to severeasthma@newcastle.edu.au

Respirology – Editor’s Choice

Respirology Issue 23.10 (October 2018)

Annual Southeast Asia haze increases respiratory admissions: A 2-year large single institution experience.

Chew R. Ming, Andrea Ban Yu‐Lin, Mohammad F. Abdul Hamid, Mohd T. Latif, Nurashikin Mohammad, Tidi Hassan

DOI: 10.1111/resp.13325

 

Satellite image of the 2015 SE-Asia haze

 

GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance detection of endobronchial tuberculosis

Qin Zhang, Qing Zhang, Bing‐qi Sun, Chang Liu, An‐na Su, Xiao‐han Wang, Na Liu, Juan Zhang, Jian Kang, Gang Hou

DOI: 10.1111/resp.13316

 

The research team from Shenyang, China, with the GeneXpert MTB/RIF system. From left to right: Xiao-han Wang, Chang Liu, Qin Zhang, Bing-qi Sun (front row); Qing Zhang, Gang Hou, An-na Su, Na Liu (Back row).

Research Project and Survey Requests

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 

.

VOLUME 7.06 – JULY 2022

VOLUME 3.06 SEPTEMBER 2018

Research Roundup:

September 2018

.
 

Welcome Message

Like many of our members, we have recently returned from the European Respiratory Society Congress where an overwhelming amount of scientific and clinical advances, discussions and debates were had over five days. The abstracts for most sessions can be found here and the limbic have provided us with some articles below highlighting key messages.

Our members had a very successful meeting and we applaud the work by the numerous TSANZ members who were recognised by the ERS for their research, including;

  • Peter Gibson – ERS Gold Medal in Asthma
  • Jodie Simpson – ERS Romain Pauwels Research Award
  • Gary Anderson – ERS Presidential Award
  • Sally Yunsun Kim – Co-funded Long-Term Research Fellowship 2018.
  • Pawan Sharma – Short-term Research Fellowship – April 2018 round
  • Louisa Organ – ERS Fellowship Recipient 2017-2019
  • Louisa Owens – ERS Grant for Best Abstract in Paediatric Respiratory Physiology
  • David Currow – ERS Grant for Best Abstract in Rehabilitation and Chronic Care
  • Deborah Reynolds-Sandford – ERS/ELS Travel Grant for Best Abstract in Patient-Centred Research

Looking ahead, abstracts to the TSANZSRS19 are closing soon, on the 12th of October. This ASM is themed Respiratory Infection and you will begin to see some exciting plenaries, workshops and symposiums online as the program is populated.

We are pleased to announce that the Maurice Blackburn Grant-in-Aid for Occupational Lung Disease and the Maurice Blackburn ASM Travel Award for allied health and nursing are now open. We would also like to remind you that two LFA awards are still open for submissions, including the LFA Cochrane Airways Australia Scholarship 2019 and the LFA David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019

The full list of awards and more information on these can be found in the Open Awards section of this newsletter and on the TSANZ Awards Submissions Portal.

Enjoy the September edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease – closes 18 Nov 18

Maurice Blackburn ASM Travel Award – closes 18 Nov 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Lung Foundation Australia Awards

The Lung Foundation Australia David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019 – closes 10 Oct 18

Lung Foundation Australia/ Cochrane Airways Australia Scholarship 2019 – closes 2 Nov 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

The Next TSANZ Webinar!

Thursday 11th October 2018

1pm AEDT | 2pm NZDT

Research Techniques to Study Respiratory Diseases – Prof Phil Hansbro

The webinar will be discussing a range of techniques that are valuable for studying disease, identifying new therapeutic targets and testing novel treatments. 

Professor Phil Hansbro Biography:

Professor Hansbro is a group leader and holds a personal chair in immunology and microbiology at the Hunter Medical Research Institute and University of Newcastle, Australia and is Associate Director of the Priority Research Centre for Asthma and Respiratory Diseases there. He is also an NHMRC Principal Research Fellow. He has established internationally recognised research programs in infections, COPD, asthma and recently lung cancer. His group has developed several novel mouse models of the important diseases (COPD, severe, steroid-insensitive asthma, early life infection & lung cancer). He has interrogated them (immune, histological, pathological, lung function & molecular analysis) to substantially further our understanding of pathogenesis and to develop novel therapies. He performs complimentary collaborative clinical and multi-disciplinary studies and collaborates widely. He publishes extensively in influential journals and he is regularly invited to present internationally including as plenary and to chair sessions. He has a substantial funding record of obtaining nationally competitive grants that support his group. He undertakes substantial mentoring and supervision activities of junior researchers, regularly sits on grant review panels and is on the editorial board of 4 journals. He is an active advocate for respiratory research in lobby groups and is regularly in the press promoting research and funding.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars with Professor Allan Glanville and Sally Powell are now available for on-demand viewing. For more information, please CLICK HERE!

________________________________________________________________________________

Respirology – Editor’s Choice

Respirology Issue 23.9 (September 2018)

Increased risk of acute coronary syndrome in patients with bronchiectasis: A population-based cohort study

Chin‐Tun Hung, Shu‐Fen Li, Wei‐Sheng Chung

DOI: 10.1111/resp.13298

 

Research team from the Taichung Hospital and Central Taiwan University of Science and Technology in Taiwan. From left to right: Drs Chin-Tun Hung, Shu-Fen Li and Wei-Sheng Chung

 

Cost-effectiveness of endobronchial valve treatment in patients with severe emphysema compared to standard medical care

Jorine E. Hartman, Karin Klooster, Henk Groen, Nick H.T. ten Hacken, Dirk‐Jan Slebos

DOI: 10.1111/resp.13295

 

Endobronchial valve (EBV), with permission from PulmonX

Pulmonary Fibrosis Awareness month

It is Pulmonary Fibrosis Awareness month and Respirology have a number of articles available as a Topic in Focus. The collection includes a TSANZ position statement and these Articles will be freely available in the awareness month of September.

 

 

Research Project and Survey Requests

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X